SCHEMBL4857575

SCHEMBL4857575

N#C/C(=C\C=C(c1ccccc1)c1ccccc1)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.44
ALDH1A1 P00352 6/20 0.44
KDM4E B2RXH2 5/20 0.44
PKM P14618 3/20 0.44
ATM Q13315 1/20 0.44
LMNA P02545 1/20 0.44
MCL1 Q07820 2/20 0.43
EGFR P00533 2/20 0.43
HPGD P15428 2/20 0.43
CISD1 Q9NZ45 1/20 0.43
SLC16A3 O15427 1/20 0.43
CYP3A4 P08684 1/20 0.43
SLC16A1 P53985 1/20 0.43
GPR35 Q9HC97 1/20 0.43
ERBB2 P04626 1/20 0.42
MAPT P10636 2/20 0.41
POLB P06746 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2807525 1.00 KMT2A (0.44) KMT2AALDH1A1KDM4EPKMATM
SCHEMBL2807530 1.00 KMT2A (0.44) KMT2AALDH1A1KDM4EPKMATM
SCHEMBL11941275 0.82 MAPT (0.49) KMT2AALDH1A1HPGDSLC16A3SLC16A1
SCHEMBL1576724 0.82 POLB (0.46) KMT2AALDH1A1KDM4EPKMATM
SCHEMBL1576722 0.82 POLB (0.46) KMT2AALDH1A1KDM4EPKMATM
SCHEMBL14163400 0.80 DNM1 (0.46) KMT2AALDH1A1KDM4EPKMATM
SCHEMBL17466006 0.78 MAPT (0.52) KMT2AALDH1A1KDM4EATMLMNA
SCHEMBL11941574 0.77 MAPT (0.48) KMT2AALDH1A1HPGDSLC16A3SLC16A1
SCHEMBL11435558 0.76 NFE2L2 (0.53) KMT2AALDH1A1KDM4EPKMATM
SCHEMBL11435556 0.76 NFE2L2 (0.53) KMT2AALDH1A1KDM4EPKMATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1535947-B1 Diorganosiloxane derivatives containing a 4,4-diarylbutadiene moiety, sunscreen compositions containing them and their uses OREAL (FR) 2010-01-06 EP disclosed
US-7432386-B2 Diarylbutadiene-substituted methyltrialkylsilanes and photoprotective compositions comprised thereof L'OREAL (FR) 2008-10-07 US disclosed
US-20070213547-A1 For UV-photoprotecting human skin against the damaging effects of UV-radiation, notably UV-A radiation; example: monotrimethylsilanylmethyl monoethyl diester of (3,3-diphenyl-2-propylidene)propanedioic acid; good resistance to water and to perspiration L'OREAL 2007-09-13 US disclosed
US-7229609-B2 Diarylbutadiene-substituted methyltrialkylsilanes and photoprotective compositions comprised thereof L'OREAL (FR) 2007-06-12 US disclosed
US-20050201957-A1 Diarylbutadiene-substituted methyltrialkylsilanes and photoprotective compositions comprised thereof L'OREAL (FR) 2005-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213547-A1 For UV-photoprotecting human skin against the damaging effects of UV-radiation, notably UV-A radiation; example: monotrimethylsilanylmethyl monoethyl diester of (3,3-diphenyl-2-propylidene)propanedioic acid; good resistance to water and to perspiration CUTA, DDB1, DCLRE1A KMT2A 2767/4885ALDH1A1 109/4885KDM4E 1149/4885
US-20050201957-A1 Diarylbutadiene-substituted methyltrialkylsilanes and photoprotective compositions comprised thereof MGMT, DDB1, ERCC1 KMT2A 793/4885ALDH1A1 333/4885KDM4E 216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.